What is Vericel's cash & equivalents?

Vericel (VCEL) reported cash & equivalents of $109.3M in Q1 2026.

How has Vericel's cash & equivalents changed year-over-year?

Vericel's cash & equivalents increased by 37.1% year-over-year, from $79.71M to $109.3M.

What is the long-term trend for Vericel's cash & equivalents?

Over 5 years (2020 to 2025), Vericel's cash & equivalents has grown at a 24.2% compound annual growth rate (CAGR), from $33.83M to $100.09M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Vericel VCEL Cash & Equivalents

Cash & Equivalents at other companies

StrykerSYK

$2.88B+24.1%

Zimmer Biomet HoldingsZBH

$424.2M-69.4%

LeMaitre VascularLMAT

$26.85M+6.0%

Capricor TherapeuticsCAPR

$105.42M+266%

Globus MedicalGMED

$560.95M+21.6%

Johnson & JohnsonJNJ

$21.69B-43.6%

Other financials

Income statement

See full

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

See full

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

See full

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

See full

Market cap$2.06B-26.8%

Enterprise value$2.05B-28.0%

P/E96.1×-850×

P/S7.1×-4.7×

Profitability

See full

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

See full

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vericel's cash & equivalents?: Vericel (VCEL) reported cash & equivalents of $109.3M in Q1 2026.
How has Vericel's cash & equivalents changed year-over-year?: Vericel's cash & equivalents increased by 37.1% year-over-year, from $79.71M to $109.3M.
What is the long-term trend for Vericel's cash & equivalents?: Over 5 years (2020 to 2025), Vericel's cash & equivalents has grown at a 24.2% compound annual growth rate (CAGR), from $33.83M to $100.09M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.